Steve Elms sold $8.8M of ADMA
director at ADMA BIOLOGICS, INC.. 425,621 shares at an average of $20.74, traded Jun 12, 2025, filed Jun 16, 2025.
Score components
- +15RoleDirector
- +25Trade size$8.8M at market
- +5Share of holdings soldSold 20% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.3%, 3m -25.0%, 6m -3.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-022713, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: See footnote | -92,941 | $21.69 | $2.0M | 2,031,730 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +9,000 | $5.96 | $54k | 96,330 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +10,000 | $5.00 | $50k | 106,330 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +53,837 | $3.66 | $197k | 160,167 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +17,500 | $4.91 | $86k | 177,667 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +30,000 | $3.89 | $117k | 207,667 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +15,000 | $2.92 | $44k | 222,667 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +55,000 | $2.35 | $129k | 277,667 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +53,172 | $1.67 | $89k | 330,839 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +51,630 | $3.35 | $173k | 382,469 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Common Stock | +37,541 | $5.40 | $203k | 420,010 | Jun 16, 2025 |
| Jun 13, 2025 | SOpen-market sale Common Stock | -137,931 | $20.82 | $2.9M | 282,079 | Jun 16, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stock | -194,749 | $20.24 | $3.9M | 87,330 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -9,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -53,837 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -17,500 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -15,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -53,172 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -51,630 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -37,541 | $0.00 | $0 | 0 | Jun 16, 2025 |
Related signals
Other insiders at ADMA BIOLOGICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $51k 6,400 shares | +1% | |
| 48Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +2% | |
| 43Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +3% | |
| 12Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $318k 21,000 shares | -1% | |
| 24Weak | ADMA BIOLOGICS, INC. | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | $158k 10,096 shares | -2% | |
| 30Weak | ADMAbuy ADMA BIOLOGICS, INC. | Steve Elms director | $217k 14,000 shares | +1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $338k 21,000 shares | -1% | |
| 6Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $416k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.